Radiocobalt theranostic applications: current landscape, challenges, and future directions
Radiocobalt-based theranostics has emerged as a promising platform in nuclear medicine that offers dual capabilities for both diagnostic imaging and targeted radionuclide therapy. 55Co (t1/2 = 17.53 h, β+ = 77%, Eγ = 931.1 keV, Iγ = 75%) and 58mCo (t1/2 = 9.10 h, IC = 100%) serve as an elementally m...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Frontiers Media S.A.
2025-08-01
|
| سلاسل: | Frontiers in Nuclear Medicine |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.frontiersin.org/articles/10.3389/fnume.2025.1663748/full |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|